Skip to content

Effects of Inspiratory Muscle Training After Lung Cancer Surgery, a Randomized Controlled Trial

Respiratory Muscle Strength, Functional Capacity and Subjective Outcome - Effects of Inspiratory Muscle Training After Lung Cancer Surgery, a Randomized Controlled Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01793155
Enrollment
70
Registered
2013-02-15
Start date
2012-11-30
Completion date
2014-12-31
Last updated
2015-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Surgery

Keywords

Lung cancer surgery, Inspiratory muscle training, Postoperative pulmonary complications, Functional outcomes, Health related quality of life

Brief summary

The purpose of this study is to evaluate the effects of postoperative inspiratory muscle training on the recovery of respiratory muscle strength in high risk patients referred for lung cancer surgery. Furthermore, to assess longitudinal changes in respiratory muscle strength, physical capacity and health-related quality of life after lung cancer surgery

Detailed description

Advances in early detection and treatment improve life expectancy after surgery for lung cancer, but living with lung cancer is frequently associated with symptoms as dyspnoea, decreased physical capacity and fatigue several years after treatment. Lung cancer (LC) surgery is associated with a high incidence of postoperative pulmonary complications (PPC), having a negative impact on recovery. Although the causes of PPC are multifactorial, respiratory muscle (RM) dysfunction has been proposed to be associated with the development of PPC, explained by changes in RM mechanics- and function due to surgery. There is scarcity of literature on the impact of RM dysfunction on surgical and functional outcomes after LC surgery. Aims: to describe longitudinal changes in RM strength in patients undergoing lung cancer surgery and identify associations between RM strength and functional capacity. Furthermore, to evaluate the effect of inspiratory muscle training on the recovery of respiratory muscle strength in high risk patients referred for LC surgery. Target population: 88 patients referred for lung cancer surgery at the Department of Cardiothoracic Surgery, Aalborg Universityhospital. Design: The core of this research is a prospective longitudinal observational study (study 1); included is a randomized controlled trial, based on a subpopulation from study 1. Statistical analysis is based on mixed linear regression models and ANOVA. For the RCT we use the generalized estimating equivalent method for parametric and Fisher´s exact test for nonparametric data.

Interventions

OTHERInspiratory muscle training

Inspiratory muscle training, as a supplement to placebo comparator, starts the day before surgery and continues for two weeks after surgery. No sessions are performed on the surgery day. Each session consists of 2 sets of 30 inspirations with a pause between each set of 2 minutes. The target intensity before surgery is 30% of the measured MIP and starts at 15% after surgery. The intensity is incrementally increased by 2 cm H20 the first days after surgery. Patients grade their perceived exertion and register eventual adverse effects in a training diary.

OTHERPlacebo comparator: standard physiotherapy

Standard physiotherapy - preoperative instruction and postoperative breathing exercises using positive expiratory pressure device (PEP) 3x10 breathings hourly during daytime, cough/huff for mucus clearance purpose, advice on early and active mobilization

Sponsors

Region Örebro County
CollaboratorOTHER
Örebro University, Sweden
CollaboratorOTHER
KU Leuven
CollaboratorOTHER
Aalborg University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>18 years; scheduled for thoracic surgery on the suspicion/confirmed lung tumor via open thoracotomy or Visual Assisted Thoracotomy(includes primary lung cancer, metastases from other cancer sites without activity within none year, other tumor types requiring resection of lung tissue; Furthermore, for RCT, one of the following: Age ≥ 70 years or FEV1 ≤ 70% predicted or DLCO ≤ 70% predicted or scheduled pneumonectomy)

Exclusion criteria

* physical or mental deficits that adversely influence physical performance; can neither speak nor read Danish; previous ipsilateral lung resection; tumor activity in other sites or organs; pancoast tumor

Design outcomes

Primary

MeasureTime frameDescription
Change in inspiratory muscle strengthBefore surgery, 5.postoperative day, 2 weeks after surgeryChange from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery

Secondary

MeasureTime frameDescription
Change in expiratory muscle strengthBefore surgery, 5 th postoperative day and 2 weeks after surgeryChange from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery
Incidence of postoperative pulmonary complications2 weeks after surgery

Other

MeasureTime frameDescription
Change in EORTC QLQ-C30-LC13Before surgery and 2 weeks after surgery
Change in EQ-5D-5LBefore surgery and 2 weeks after surgery
Change in walking distance, 6 minutebefore surgery, 5th postoperative day and 2 weeks after surgeryChange from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery
Change in numeric rang score for painBefore surgery, 5th postoperative day and 2 weeks after surgeryChange from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery
Change in numeric rang score for cough efficiency5th postoperative day and 2 weeks after surgery
Change in Physical Activity Score- PASBefore surgery and 2 weeks after surgery
Change in spirometry values(FVC, FEV1)before surgery, 5th day, 2 weeks after surgeryChange from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery
Change in Borg CR-10 dyspneaBefore surgery, 5th postoperative day and 2 weeks after surgeryChange from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026